Report - Efficacy and safety of ixekizumab through 52 weeks in two ... · 176 Dougados M, etfial.Ann Rheum dis 2020;79:176–185. doi:10.1136/annrheumdis-2019-216118 Spondyloarthritis CliniCal

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form